Discovery of enzyme in the sleeping sickness parasite streamlines drug development

Posted by on April 18, 2016 1:13 pm
Categories: health

The single-celled parasite causing African sleeping sickness has a defense mechanism against potential pharmaceuticals under development against the disease, new research indicates. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals.

Leave a Reply

Your email address will not be published. Required fields are marked *